Trevor Hallam

Trevor Hallam

Company: Sutro Biopharma

Job title: Chief Scientific Officer


Tumor-Targeted In Situ Immunization; Off-The Shelf & Systemically-Administered 8:30 am

• Re-assessing the role of cytotoxins as stimulators of immunogenic cell death in propogating more robust immune response • Targeted immunostimulators generate innate immune responses to tumors while increasing systemic tolerability • Homogeneous combination conjugates of mechanistically different payloads to an antibody opens up systemically administered “in situ immunisation”Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.